These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33731436)

  • 1. GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein.
    Nakamura M; Li Y; Choi BR; Matas-Rico E; Troncoso J; Takahashi C; Sockanathan S
    Sci Transl Med; 2021 Mar; 13(585):. PubMed ID: 33731436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK.
    Park S; Lee C; Sabharwal P; Zhang M; Meyers CL; Sockanathan S
    Science; 2013 Jan; 339(6117):324-8. PubMed ID: 23329048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
    Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
    EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP.
    Zhang J; Jiang Y; Dong X; Meng Z; Ji L; Kang Y; Liu M; Zhou W; Song W
    Alzheimers Res Ther; 2024 Jul; 16(1):160. PubMed ID: 39030577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bioengineering Strategy to Control ADAM10 Activity in Living Cells.
    Pastore F; Battistoni M; Sollazzo R; Renna P; Paciello F; Li Puma DD; Barone E; Dagliyan O; Ripoli C; Grassi C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
    Hitschler L; Lang T
    J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.
    Manzine PR; Ettcheto M; Cano A; Busquets O; Marcello E; Pelucchi S; Di Luca M; Endres K; Olloquequi J; Camins A; Cominetti MR
    Biomed Pharmacother; 2019 May; 113():108661. PubMed ID: 30836275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons.
    Mei Z; Situ B; Tan X; Zheng S; Zhang F; Yan P; Liu P
    Brain Res; 2010 Aug; 1348():165-73. PubMed ID: 20595051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4-Diacetylphloroglucinol Reduces Beta-Amyloid Production and Secretion by Regulating ADAM10 and Intracellular Trafficking in Cellular and Animal Models of Alzheimer's Disease.
    Jang BG; Choi B; Kim S; Lee DS; Lee J; Koh YH; Jo SA; Kim JE; Kang TC; Kim MJ
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2.
    Lichtenthaler SF; Tschirner SK; Steiner H
    Curr Opin Neurobiol; 2022 Feb; 72():101-110. PubMed ID: 34689040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.
    Colombo A; Wang H; Kuhn PH; Page R; Kremmer E; Dempsey PJ; Crawford HC; Lichtenthaler SF
    Neurobiol Dis; 2013 Jan; 49():137-47. PubMed ID: 22940630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.
    Kuhn PH; Wang H; Dislich B; Colombo A; Zeitschel U; Ellwart JW; Kremmer E; Rossner S; Lichtenthaler SF
    EMBO J; 2010 Sep; 29(17):3020-32. PubMed ID: 20676056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-Specific Activation of α-Secretase by 7-Deoxy-Trans-Dihydronarciclasine Increases Non-Amyloidogenic Processing of β-Amyloid Protein Precursor.
    Chun YS; Cho YY; Kwon OH; Zhao D; Yang HO; Chung S
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32028607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
    Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer's disease.
    Agüero P; Sainz MJ; García-Ayllón MS; Sáez-Valero J; Téllez R; Guerrero-López R; Pérez-Pérez J; Jiménez-Escrig A; Gómez-Tortosa E
    Alzheimers Res Ther; 2020 Oct; 12(1):139. PubMed ID: 33129344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
    Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
    Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
    Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
    J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
    Carey RM; Blusztajn JK; Slack BE
    BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.